Confirmatory Trials for Drugs Granted Conditional Approval by the Chinese National Medical Products Administration

JAMA Health Forum. 2024 Dec 6;5(12):e244601. doi: 10.1001/jamahealthforum.2024.4601.

Authors

Yun Tian^{1

2

3}, Xiaoyong Liu^{1

2}, Xingyu Liu^{1

2}, Jinwei Zhang^{1

2}, Shuchen Hu^{1

2}, Caijun Yang^{1

2}, Yu Fang^{1

2}

Affiliations

¹ Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi'an Jiaotong University, Xi'an, China.
² Center for Drug Safety and Policy Research, Xi'an Jiaotong University, Xi'an, China.
³ Department of Pharmacy, Shaanxi Provincial Cancer Hospital, Xi'an, China.

PMID: 39729303
DOI: 10.1001/jamahealthforum.2024.4601

No abstract available

Plain language summary

This cross-sectional study analyzes differences in pivotal and confirmatory trial characteristics for drugs granted conditional approval in China.